Tradestie Institutional Equity Comparison Engine

FEMY vs KMTS โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

KMTS Overall Edge

KMTS Captures Institutional Edge (1โ€“1 Pillars ยท 6โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Kestra Medical Technologies, Ltd. Common Stock (KMTS) driven by superior Growth & Margin while FEMY counters with relative strength in Momentum & Technical. Fundamentally, FEMY trades at N/M Forward P/E with -763.9% operating margin (-18.9% YoY revenue) versus KMTS at N/M Forward P/E and -134.5% operating margin (+59.9% YoY). In options structure, FEMY sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against KMTS sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
FEMY N/M vs KMTS N/M Fwd P/E
Growth & Margin Winner KMTS
Op Margin -763.9% vs -134.5% ยท YoY -18.9% vs +59.9%
Momentum & Technical Winner FEMY
1Y +54.8% vs +12.3% ยท 52W Pos 17% vs 73%
Options & Structure Winner Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
FEMY NASDAQ
Femasys Inc. Common Stock
Surgical & Medical Instruments & Apparatus
$1.28
-9.86% 1D
Market Cap $11.9M
1M Return -22.42%
1Y Return +54.78%
Forward P/E N/M
Unified AI Score
52.6 / 100 HOLD
Tech 61.0 Fund 62.0 Flow 50.0 Mom 64.0
KMTS NASDAQ
Kestra Medical Technologies, Ltd. Common Stock
Surgical & Medical Instruments & Apparatus
$27.97
-2.34% 1D
Market Cap $1.7B
1M Return +2.68%
1Y Return +12.28%
Forward P/E N/M
Unified AI Score
43.8 / 100 HOLD
Tech 21.0 Fund 39.0 Flow 50.0 Mom 40.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: FEMY +54.78% KMTS +12.28% Spread: +42.5 pp (FEMY Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period FEMY Revenue KMTS Revenue FEMY Op. Margin KMTS Op. Margin Margin Edge
FY2020 $0M N/A -668.0% N/A FEMY
FY2021 $0M N/A -706.7% N/A FEMY
FY2022 $0M N/A -961.7% N/A FEMY
FY2023 $0M N/A -1353.4% N/A FEMY
FY2024 $0M $30M -1091.8% -305.8% KMTS
FY2025 $0M $60M -767.0% -177.8% KMTS
FY2026 N/A $100M N/A -141.6% KMTS

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: FEMY (2) vs KMTS (6)
Institutional Metric FEMY KMTS Criterion Row Winner
Market Capitalization Scale $11.9M $1.7B Larger Scale KMTS
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth -18.9% +59.9% Higher Growth KMTS
Operating Margin (TTM) Profitability -763.9% -134.5% Higher Margin KMTS
Net Profit Margin Profitability 0.0% -140.4% Higher Margin FEMY
Return on Equity (ROE) Capital Efficiency -425.0% -73.7% Higher ROE KMTS
52-Week Range Position Momentum 17% ($0โ€“$6) 73% ($17โ€“$32) Stronger Trend KMTS
Beta / 30D Volatility Risk Regime 4.01ฮฒ ยท 72% Vol 1.84ฮฒ ยท 63% Vol Lower Realized Risk KMTS
Unified Institutional Score Composite Signal 52.6 / 100 (HOLD) 43.8 / 100 (HOLD) Higher Composite FEMY

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full FEMY vs KMTS Buy Guide
FEMY UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live FEMY Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
KMTS UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live KMTS Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither FEMY nor KMTS registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.